For only a few of the congenital mutations functional and/or biochemical consequences have been studied and, interestingly, some of these map close to the positions of the mutations in ACTB or ACTG1 in DLBCL or multiple myeloma. This evidence concerns the gene ACTB and diffuse large B-cell lymphoma.